Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) COO Daniel Lesueur sold 5,209 shares of the business's stock in a transaction that occurred on Thursday, April 3rd. The stock was sold at an average price of $4.15, for a total value of $21,617.35. Following the sale, the chief operating officer now owns 211,041 shares of the company's stock, valued at approximately $875,820.15. This trade represents a 2.41 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.
Daniel Lesueur also recently made the following trade(s):
- On Wednesday, March 5th, Daniel Lesueur sold 16,902 shares of Health Catalyst stock. The stock was sold at an average price of $4.52, for a total value of $76,397.04.
- On Wednesday, February 5th, Daniel Lesueur sold 5,209 shares of Health Catalyst stock. The shares were sold at an average price of $5.76, for a total value of $30,003.84.
Health Catalyst Price Performance
HCAT stock opened at $3.99 on Tuesday. Health Catalyst, Inc. has a 52-week low of $3.72 and a 52-week high of $9.24. The company has a quick ratio of 1.41, a current ratio of 1.41 and a debt-to-equity ratio of 0.32. The stock has a market cap of $280.14 million, a price-to-earnings ratio of -2.96 and a beta of 1.43. The business has a fifty day moving average of $4.85 and a two-hundred day moving average of $6.67.
Institutional Trading of Health Catalyst
Hedge funds and other institutional investors have recently modified their holdings of the business. Quantbot Technologies LP acquired a new position in Health Catalyst in the fourth quarter valued at about $29,000. Group One Trading LLC lifted its holdings in shares of Health Catalyst by 107.6% in the 4th quarter. Group One Trading LLC now owns 4,360 shares of the company's stock worth $31,000 after acquiring an additional 2,260 shares during the last quarter. Aquatic Capital Management LLC purchased a new position in shares of Health Catalyst during the 4th quarter worth approximately $63,000. Stoneridge Investment Partners LLC acquired a new stake in Health Catalyst in the 4th quarter valued at approximately $77,000. Finally, Martin Worley Group purchased a new stake in Health Catalyst in the fourth quarter valued at approximately $78,000. 85.00% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
HCAT has been the topic of several recent research reports. Citigroup lowered their target price on shares of Health Catalyst from $10.50 to $10.00 and set a "buy" rating on the stock in a research note on Friday, January 10th. Wells Fargo & Company dropped their price objective on shares of Health Catalyst from $13.00 to $10.00 and set an "overweight" rating for the company in a research note on Tuesday, January 21st. Royal Bank of Canada decreased their target price on shares of Health Catalyst from $7.00 to $6.00 and set a "sector perform" rating on the stock in a research note on Thursday, February 27th. Stifel Nicolaus dropped their price target on Health Catalyst from $10.00 to $5.00 and set a "hold" rating for the company in a research report on Thursday, February 27th. Finally, Canaccord Genuity Group reduced their price objective on Health Catalyst from $11.00 to $10.00 and set a "buy" rating on the stock in a research report on Tuesday, January 21st. Three research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $9.27.
View Our Latest Research Report on Health Catalyst
Health Catalyst Company Profile
(
Get Free Report)
Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
